Altasciences Featured Content

  1. Advances In Metabolic Research: Beyond GLP-1 7/15/2026

    GLP-1 therapies are expanding fast, from T2D into obesity, MASH, and neurology. Learn how next-gen multi-agonist incretins, a case study, and market forecasts for patients can shape your strategy.

  2. Strong Regulatory Foundations For Early-Phase Drug Development 6/17/2026

    Discover how an integrated regulatory strategy can help streamline development and accelerate your path to the clinic.

  3. Regulatory Pathways By Region: A Guide For Early-Phase Trials 6/17/2026

    Explore key regulatory considerations across major global markets to support more efficient early-phase clinical development planning.

  4. Project Management: Where Science, Strategy, And Operations Converge 5/11/2026

    Stop chasing updates and take control of your program. Learn how our integrated project management services improve visibility, reduce risk, and keep your studies on track.

  5. Clinical Innovation Meets Manufacturing Excellence 10/7/2025

    Discover how our ClinDMO model transforms early drug development with on-demand manufacturing, adaptive formulation, and real-time decision-making to accelerate timelines and optimize API use.

  6. Clinical Trials Without Boundaries: Multi-Site Solutions At Altasciences 8/21/2025

    Altasciences offers flexible clinical trial models — from single-site to multi-center — to accelerate recruitment, expand patient access, and ensure high-quality trials aligned with your protocol.

  7. Central Nervous System (CNS) Drug Development, Simplified 7/9/2025

    Discover a global CNS leader with 200+ studies completed to date and end-to-end drug development expertise—bridging translational gaps and accelerating your path from discovery to delivery.

  8. Challenges With Hallucinogens, Psychedelics, And Entactogens 5/9/2025

    This eBook examines the complex regulatory landscape and the preclinical, clinical, and manufacturing challenges involved in developing Schedule 1 therapeutics.

  9. Safety Assessment For Ophthalmic Products 2/20/2025

    Dive into the world of ophthalmic drug development, where careful considerations in the preclinical phase must be taken to facilitate advancement into first-in-human clinical trials.

  10. Comprehensive Services For Ophthalmic Drug Development 2/20/2025

    To maximize bioavailability while preserving vision and maintaining the structural integrity of the eye, formulation and delivery strategies must be meticulously designed.